Boehringer Ingelheim Fonds | Titisee Conferences

100. ITC	2009,	Oct. 14 - Oct. 18	Axel Meyer, Konstanz, Germany Yves Van de Peer, Ghent, Belgium Genome evolution and the origin of novel gene functions
99. ITC	2009,	Mar. 25 - Mar. 29	Bernd Bukau,Heidelberg, Germany Stefan Jentsch, Martinsried, Germany Cellular safeguards and quality control
98. ITC	2008,	Nov. 05 - Nov. 09	Rudolf Jaenisch,Cambridge, MA, USA, Thomas Graf, Barcelona, Spain Differentiation, reprogramming and regeneration
97. ITC	2008,	Mar. 12 - Mar. 16	Anne Ridley, London, UK Matthias Peter, Zurich, Switzerland Mechanisms of Cell Polarity
96. ITC	2007,	Nov. 14 - Nov. 18	Stefan W. Hell, Göttingen, Germany Jörg Enderlein, Tübingen, Germany Trends in Biological Optical Microscopy
95. ITC	2007,	Apr. 11 - Apr. 15	Jan Hoeijmakers, Rotterdam, The Netherlands Judy Campisi, Berkeley, CA, USA Molecular basis of aging
94. ITC	2006,	Nov. 15 - Nov. 19	Wolf Singer, Frankfurt/Main, Germany The dynamical brain
93. ITC	2006,	Mar. 29 - Apr. 02	U. Benjamin Kaupp, Jülich, Germany Michael Eisenbach, Rehovot, Israel Mechanisms of chemotaxis
92. ITC	2005,	Oct. 19 - Oct. 23	Meinrad Busslinger, Vienna, Austria Stem cells and haematopoietic tumours
91. ITC	2005,	Apr. 06 - Apr. 10	Hidde Ploegh, Boston, MA, USA Cell biology meets the immune system: molecular aspects of host-pathogen interactions
90. ITC	2004,	Oct. 21 - Oct. 24	Thomas Tuschl, New York, NY, USA Thomas Jenuwein, Vienna, Austria RNA silencing
89. ITC	2004,	Mar. 17 - Mar. 21	Rudolf Valenta, Vienna, Austria Thomas Brocker, Munich, Germany From allergy to cancer: new perspectives for therapeutic vaccination
88. ITC	2003,	Oct. 22 - Oct. 26	Jürgen Klingauf, Göttingen, Germany Erwin Neher, Göttingen, Germany Synaptic transmission: from molecules to circuits
87. ITC	2003,	Mar. 19 - Mar. 23	Christian Haass, Munich, Germany Roger Nitsch, Zurich, Switzerland Alzheimer's and Parkinson's disease – from basic research to therapeutic treatment
86. ITC	2002,	Oct. 23 - Oct. 27	Franz Xaver Schmid, Bayreuth, Germany Reinhard Sterner, Köln, Germany Protein design at the crossroads of biotechnology, chemistry, theory and evolution
85. ITC	2002,	Mar. 13 - Mar. 17	Sabine Werner, Zurich, Switzerland Clive Dickson, London, UK Growth factors in development, repair and disease
84. ITC	2001,	Oct. 24 - Oct. 28	Alan Hall, London, UK Alfred Wittinghofer, Dortmund, FRG The actin cytoskeleton: from signalling to bacterial pathogenesis
83. ITC	2001,	Mar. 21 - Mar. 25	Veit Flockerzi, Homburg, FRG, Markus Hoth, Homburg, FRG, Walter Stühmer, Göttingen, FRG Ion channels in health and disease
82. ITC	2000,	Oct. 25 - Oct. 29	Reinhard Jahn, Göttingen, FRG Membrane fusion
81. ITC	2000,	Apr. 12 - Apr. 16	Michael Reth, Freiburg, FRG, Lawrence E. Samelson, Bethesda, MD, USA Signal processing through protein complexes
80. ITC	1999,	Nov. 04 - Nov. 07	K. Nasmyth, Vienna, Austria, M. Raff, London, UK, E. F. Wagner, Vienna, Austria Growth control in cells, organs and animals
79. ITC	1999,	Apr. 28 - May 02	P. Herrlich, Karlsruhe, FRG, H. Land, Rochester, NY, USA Parallels in cancer and embryonic development
78. ITC	1998,	Oct. 07 - Oct. 11	B. Horsthemke, Essen, FRG Molecular mechanisms in human malformation syndromes
77. ITC	1998,	Mar. 04 - Mar. 08	W. Singer, Frankfurt/Main, FRG, C. von der Malsburg, Bochum, FRG The role of time in neuronal processing
76. ITC	1997,	Oct. 15 - Oct. 19	C.-M. Becker, Erlangen, FRG, A. Aguzzi, Zurich, Switzerland Neurological diseases: models, molecules and mechanisms
75. ITC	1997,	Mar. 05 - Mar. 09	C. Nüsslein-Volhard, Tübingen, FRG, E. Wieschaus, Princeton, NJ, USA Gradients in development: formation and interpretation
74. ITC	1996,	Oct. 02 - Oct. 06	W. Franke, Heidelberg, FRG, R. Kemler, Freiburg/Breisgau, FRG Cell junctions and disease
73. ITC	1996,	Mar. 27 - Mar. 31	G. Riethmüller, München, FRG Latent infection and dormant cancer: novel strategies for immune intervention
72. ITC	1995,	Nov. 01 - Nov. 05	N. E. Fusenig, Heidelberg, FRG, P. Boukamp, Heidelberg, FRG Tumor angiogenesis and anti-angiogenesis: a major aspect in tumor-stroma interaction
71. ITC	1995,	Mar. 22 - Mar. 26	U. B. Kaupp, Jülich, FRG, G. H. Gold, Philadelphia, PA, USA Signal transduction in vision and the chemical senses
70. ITC	1994,	Oct. 05 - Oct. 09	F. Melchers, Basel, Switzerland Lymphopoiesis
69. ITC	1994,	Mar. 09 - Mar. 13	H. Rahmann, Stuttgart, FRG The neurobiology of memory formation in vertebrates: neuronal plasticity and brain function
68. ITC	1993,	Oct. 27 - Oct. 31	M. Schramm, Jerusalem, Israel, H. Betz, Frankfurt/Main, FRG Open problems in brain glutamate receptor: structure, function and neurotoxicity
67. ITC	1993,	Mar. 17 - Mar. 21	A. Starzinski-Powitz, Frankfurt/Main, FRG, D. Fischman, New York, NY, USA Molecular and cellular biology of muscle development: in vivo analysis
66. ITC	1992,	Nov. 04 - Nov. 08	W. Ostertag, Hamburg, FRG Somatic gene therapy — gene transfer and differentiation
65. ITC	1992,	Mar. 04 - Mar. 08	S. Fedoroff, Saskatoon, Saskatchewan, Canada, G. W. Kreutzberg, Planegg, FRG Neuroimmune networks: cell-cell communication and response to injury and regeneration in the CNS
64. ITC	1991,	Oct. 16 - Oct. 20	J. G. Nicholls, Basel, Switzerland Development, regeneration and plasticity of the nervous system
63. ITC	1991,	Mar. 06 - Mar. 10	G. Wick, Innsbruck, Austria Immune-endocrine interactions
62. ITC	1990,	May 09 - May 13	G. Pasternak, Berlin, GDR Monoclonal antibodies in cancer research and diagnostics
61. ITC	1990,	Mar. 28 - Apr. 01	G. Heusch, Essen, FRG Adrenergic mechanisms in myocardial ischemia
59. ITC	1989,	Apr. 12 - Apr. 16	G. A. Robison, Houston, TX, USA Drug action at the molecular level: differences between agonists and antagonists
58. ITC	1989,	Mar. 01 - Mar. 05	G. Schatten, Tallahassee, FL, USA Nuclear cytoskeletal interactions
57. ITC	1988,	Oct. 05 - Oct. 09	G. Hunsmann, Göttingen, FRG Antiretroviral chemotherapy
56. ITC	1988,	May 11 - May 15	R. Knippers, Konstanz, FRG, A. J. Levine, Princeton, NJ, USA Transforming proteins of DNA tumor viruses
55. ITC	1988,	Mar. 02 - Mar. 06	L. Heilmeyer, Bochum, FRG, E. H. Fischer, Seattle, WA, USA Signal transduction and protein phosphorylation
54. ITC	1987,	Sep. 30 - Oct. 04	H. Zur Hausen, Heidelberg, FRG Papillomavirus in human genital cancer: causative role and practical consequences
53. ITC	1987,	May 13 - May 17	H. Neurath, Seattle, WA, USA, E. W. Davie, Seattle, WA, USA, F. Melchers, Basel, Switzerland Proteolytic processing and biological function
52. ITC	1986,	Oct. 08 - Oct. 11	B. Hamprecht, Tübingen, FRG, D. Monard, Basel, Switzerland Molecular factors involved in the development of the nervous system
51. ITC	1986,	Apr. 23 - Apr. 27	B. Williamson, London, UK Human gene mapping and molecular pathology
50. ITC	1985,	Oct. 02 - Oct. 06	W. Kalow, Toronto, Ontario, Canada, H. W. Goedde, Hamburg, FRG Ethnic differences in reactions to drugs and other xenobiotics
49. ITC	1985,	May 02 - May 04	G. Weber, Indianapolis, IN, USA Enzyme pattern-targeted chemotherapy
48. ITC	1984,	Oct. 17 - Oct. 21	P. G. Spieckermann, Göttingen, FRG, H. M. Piper, Göttingen, FRG Isolated adult heart muscle cells: a new model for studies on cardiac metabolism, function and structure
47. ITC	1984,	Oct. 10 - Oct. 14	A. P. Fishman, Philadelphia, PA, USA Endothelium
46. ITC	1983,	Oct. 05 - Oct. 09	S. Brenner, Cambridge, UK Impact of modern molecular genetics on human biology and medicine
45. ITC	1983,	Mar. 17 - Mar. 19	A. Katz, Farmington, CT, USA, W. Kübler, Heidelberg, FRG Myocardial ischemia: pathogenesis, mechanism and clinical implications
	1970,	Jan. 01 - Jan. 01

Titisee Conferences

About ITCs

Selection

Upcoming ITC

How To Get There

Past Conferences

Past International Titisee Conferences